Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Devon Energy heads into its November 3 earnings with a curious split: Street conviction remains high, borrowing costs have collapsed, but short interest has crept up nearly 19% over the past month.
The most interesting story in the lending market is how quickly the borrow pressure from mid-September has unwound. Cost to borrow hit a monthly peak near 0.43% around September 15, when short interest briefly touched 32.8 million shares. Both have since retreated. Borrowing costs fell 77% on the week to just 0.09%, and availability is effectively uncapped, with over 1.1 billion shares available to lend against a short position of roughly 28.3 million. That looseness means new shorts face no friction at all. Yet despite the cheap, plentiful borrow, shorts have added about 4.5 million shares since early September, pushing the float-adjusted figure to 4.5% of free float. Options traders are running in the opposite direction. The put/call ratio closed at 0.47, more than 1.5 standard deviations below its 20-day average of 0.56. That is the most bullish options posture Devon has seen in months, sitting closer to the 52-week low of 0.25 than to the high of 1.05.
The Street's conviction broadly matches that options tilt. Analyst recommendations are skewed heavily toward buy-side ratings, and the consensus price target of $60.57 implies roughly 26% upside from the current $48.02 close. Truist trimmed its target from $65 to $61 on October 7, keeping a Buy rating. A week earlier, JP Morgan lifted its target from $60 to $65, also maintaining Overweight. Wells Fargo nudged its target down slightly to $64 on September 28, again holding Overweight. The direction of travel over the past month has been upward revisions outnumbering cuts, with Raymond James raising to $67 and UBS moving from $55 to $63. Devon scores in the 90th percentile on analyst recommendation differential, and forward EPS growth ranks in the 88th percentile. The bull case centres on 2.2 billion barrels of proved reserves, a 73% oil and natural gas liquids mix, and a $1 billion free cash flow improvement target by year-end. The bear case is familiar: a sustained oil price decline would compress the economics of the Delaware Basin and undercut the reinvestment case, with the company's maintenance spending already dropping to around 63% of strip cash flow.
One activity worth noting at the margin is CEO Clay Gaspar's open-market purchase of 3,913 shares at $51.08 on September 14. The trade was discretionary, not under a 10b5-1 plan, and came the same day the EVP of Exploration and Production sold 6,756 shares. Neither is large in absolute terms, but the CEO buying against a colleague's sale at roughly the same price is a mixed internal signal rather than a clear directional vote.
Earnings reactions at Devon have been bimodal in recent history. The last print on August 5 produced a 2.1% drop on the day but recovered to a 1.8% gain by the five-day mark. The print before that, on August 4, saw a sharper 5.6% decline on the day, again followed by a 1.9% five-day recovery. The pattern suggests the immediate post-print reaction has been negative in both recent cases, with buyers returning over the following week. Devon's closest peers have outpaced it over the past week, with OXY up 6.2% and PR up 5.4% against Devon's 3%. APA added 4.5% and CHRD lagged slightly at 2.3%. Devon's relative underperformance versus the peer group over the past week, despite its larger year-to-date gain, is the tension to watch as the November 3 print approaches.
With retail attention running at a two-and-a-half standard deviation above Devon's own 90-day norm, and short builders adding exposure into a stock where calls heavily outnumber puts, the setup into earnings is one where positioning and sentiment are pointing in opposite directions.
See the live data behind this article on ORTEX.
Open DVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
